The Food and Drug Administration deer (FDA) authorized updated vaccines against against new variants of Covid-19 that circulate in almost all countries, most of them omicron, intended to reduce hospitalizations and deaths.
In a statement, the FDA shows that the approved vaccines They are updated by mRNA for 2023-2024 and manufactured by Moderna and Pfizer. Based on the general evidence and contributions of expert advisors FDA these vaccines have been updated to include a monovalent (single) component corresponding to the XBB.1.5 omicron variant.
According to FDA people over five years of age should receive a dose of the updated vaccine at least two months after the last dose of any vaccine against Covid-19.
“Vaccination remains critical for public health and continued protection against severe consequences of Covid-19, including hospitalization and death,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.
“The public can be assured that these updated vaccines meet the agency’s rigorous scientific standards for safety, efficacy and manufacturing quality. “We strongly encourage those who are eligible to consider vaccination,” he added.
US reports are increasing in cases of an omicron subtype
The consent of FDA It became known after a surge of cases in late summer, when the new EG.5 subvariant of omicron – nicknamed “eris” – began to spread rapidly in deer and the rest of the world.
Advisors to the US Centers for Disease Control and Prevention (CDC) are scheduled to meet on Tuesday, September 12, to recommend who should receive the vaccine.
Approval from CDC Director Mandy Cohen, expected soon, should clear the way for new vaccines. Cohen stated that he expects the vaccines to be launched in September.
